Sylentis is also participating in two cooperation projects under the European Union framework program: “NANOPILOT: A Pilot Plant for the Production of Polymer-based Nanopharmaceuticals in Compliance with GMP” and “NABBA: Design and Development of advanced Nanomedicines to overcome Biological Barriers and to treat severe diseases”.